Report Detail
Global Targeted Protein Degradation Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4583823 |
- 29 March, 2024 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Targeted Protein Degradation Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Targeted Protein Degradation Drug industry chain, the market status of Cancer (PROTAC, Molecular Glue), Autoimmune Diseases (PROTAC, Molecular Glue), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted Protein Degradation Drug.
Regionally, the report analyzes the Targeted Protein Degradation Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Protein Degradation Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted Protein Degradation Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Protein Degradation Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PROTAC, Molecular Glue).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Protein Degradation Drug market.
Regional Analysis: The report involves examining the Targeted Protein Degradation Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Protein Degradation Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted Protein Degradation Drug:
Company Analysis: Report covers individual Targeted Protein Degradation Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted Protein Degradation Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Autoimmune Diseases).
Technology Analysis: Report covers specific technologies relevant to Targeted Protein Degradation Drug. It assesses the current state, advancements, and potential future developments in Targeted Protein Degradation Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Protein Degradation Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeted Protein Degradation Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
PROTAC
Molecular Glue
Market segment by Application
Cancer
Autoimmune Diseases
Other
Market segment by players, this report covers
Arvinas
Kangpu Biopharmaceuticals
Ranok Therapeutics
Accutar Biotechnology
BeiGene Ltd.
Hinova Pharmaceuticals
Haisco Pharmaceutical
Nurix
Kymera Therapeutics
C4 Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted Protein Degradation Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Protein Degradation Drug, with revenue, gross margin and global market share of Targeted Protein Degradation Drug from 2019 to 2024.
Chapter 3, the Targeted Protein Degradation Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Targeted Protein Degradation Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Protein Degradation Drug.
Chapter 13, to describe Targeted Protein Degradation Drug research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Targeted Protein Degradation Drug
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Targeted Protein Degradation Drug by Type
- 1.3.1 Overview: Global Targeted Protein Degradation Drug Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Targeted Protein Degradation Drug Consumption Value Market Share by Type in 2023
- 1.3.3 PROTAC
- 1.3.4 Molecular Glue
- 1.4 Global Targeted Protein Degradation Drug Market by Application
- 1.4.1 Overview: Global Targeted Protein Degradation Drug Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Cancer
- 1.4.3 Autoimmune Diseases
- 1.4.4 Other
- 1.5 Global Targeted Protein Degradation Drug Market Size & Forecast
- 1.6 Global Targeted Protein Degradation Drug Market Size and Forecast by Region
- 1.6.1 Global Targeted Protein Degradation Drug Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Targeted Protein Degradation Drug Market Size by Region, (2019-2030)
- 1.6.3 North America Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
- 1.6.4 Europe Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
- 1.6.6 South America Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Targeted Protein Degradation Drug Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Arvinas
- 2.1.1 Arvinas Details
- 2.1.2 Arvinas Major Business
- 2.1.3 Arvinas Targeted Protein Degradation Drug Product and Solutions
- 2.1.4 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Arvinas Recent Developments and Future Plans
- 2.2 Kangpu Biopharmaceuticals
- 2.2.1 Kangpu Biopharmaceuticals Details
- 2.2.2 Kangpu Biopharmaceuticals Major Business
- 2.2.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product and Solutions
- 2.2.4 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Kangpu Biopharmaceuticals Recent Developments and Future Plans
- 2.3 Ranok Therapeutics
- 2.3.1 Ranok Therapeutics Details
- 2.3.2 Ranok Therapeutics Major Business
- 2.3.3 Ranok Therapeutics Targeted Protein Degradation Drug Product and Solutions
- 2.3.4 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Ranok Therapeutics Recent Developments and Future Plans
- 2.4 Accutar Biotechnology
- 2.4.1 Accutar Biotechnology Details
- 2.4.2 Accutar Biotechnology Major Business
- 2.4.3 Accutar Biotechnology Targeted Protein Degradation Drug Product and Solutions
- 2.4.4 Accutar Biotechnology Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Accutar Biotechnology Recent Developments and Future Plans
- 2.5 BeiGene Ltd.
- 2.5.1 BeiGene Ltd. Details
- 2.5.2 BeiGene Ltd. Major Business
- 2.5.3 BeiGene Ltd. Targeted Protein Degradation Drug Product and Solutions
- 2.5.4 BeiGene Ltd. Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 BeiGene Ltd. Recent Developments and Future Plans
- 2.6 Hinova Pharmaceuticals
- 2.6.1 Hinova Pharmaceuticals Details
- 2.6.2 Hinova Pharmaceuticals Major Business
- 2.6.3 Hinova Pharmaceuticals Targeted Protein Degradation Drug Product and Solutions
- 2.6.4 Hinova Pharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Hinova Pharmaceuticals Recent Developments and Future Plans
- 2.7 Haisco Pharmaceutical
- 2.7.1 Haisco Pharmaceutical Details
- 2.7.2 Haisco Pharmaceutical Major Business
- 2.7.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Product and Solutions
- 2.7.4 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Haisco Pharmaceutical Recent Developments and Future Plans
- 2.8 Nurix
- 2.8.1 Nurix Details
- 2.8.2 Nurix Major Business
- 2.8.3 Nurix Targeted Protein Degradation Drug Product and Solutions
- 2.8.4 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Nurix Recent Developments and Future Plans
- 2.9 Kymera Therapeutics
- 2.9.1 Kymera Therapeutics Details
- 2.9.2 Kymera Therapeutics Major Business
- 2.9.3 Kymera Therapeutics Targeted Protein Degradation Drug Product and Solutions
- 2.9.4 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Kymera Therapeutics Recent Developments and Future Plans
- 2.10 C4 Therapeutics
- 2.10.1 C4 Therapeutics Details
- 2.10.2 C4 Therapeutics Major Business
- 2.10.3 C4 Therapeutics Targeted Protein Degradation Drug Product and Solutions
- 2.10.4 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 C4 Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Targeted Protein Degradation Drug Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Targeted Protein Degradation Drug by Company Revenue
- 3.2.2 Top 3 Targeted Protein Degradation Drug Players Market Share in 2023
- 3.2.3 Top 6 Targeted Protein Degradation Drug Players Market Share in 2023
- 3.3 Targeted Protein Degradation Drug Market: Overall Company Footprint Analysis
- 3.3.1 Targeted Protein Degradation Drug Market: Region Footprint
- 3.3.2 Targeted Protein Degradation Drug Market: Company Product Type Footprint
- 3.3.3 Targeted Protein Degradation Drug Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Targeted Protein Degradation Drug Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Targeted Protein Degradation Drug Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Targeted Protein Degradation Drug Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Targeted Protein Degradation Drug Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
- 6.2 North America Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
- 6.3 North America Targeted Protein Degradation Drug Market Size by Country
- 6.3.1 North America Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
- 6.3.2 United States Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 6.3.3 Canada Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
- 7.2 Europe Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
- 7.3 Europe Targeted Protein Degradation Drug Market Size by Country
- 7.3.1 Europe Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
- 7.3.2 Germany Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 7.3.3 France Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 7.3.5 Russia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 7.3.6 Italy Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Targeted Protein Degradation Drug Market Size by Region
- 8.3.1 Asia-Pacific Targeted Protein Degradation Drug Consumption Value by Region (2019-2030)
- 8.3.2 China Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 8.3.3 Japan Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 8.3.5 India Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 8.3.7 Australia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
- 9.2 South America Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
- 9.3 South America Targeted Protein Degradation Drug Market Size by Country
- 9.3.1 South America Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Country
- 10.3.1 Middle East & Africa Targeted Protein Degradation Drug Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
- 10.3.4 UAE Targeted Protein Degradation Drug Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Targeted Protein Degradation Drug Market Drivers
- 11.2 Targeted Protein Degradation Drug Market Restraints
- 11.3 Targeted Protein Degradation Drug Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Targeted Protein Degradation Drug Industry Chain
- 12.2 Targeted Protein Degradation Drug Upstream Analysis
- 12.3 Targeted Protein Degradation Drug Midstream Analysis
- 12.4 Targeted Protein Degradation Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Targeted Protein Degradation Drug. Industry analysis & Market Report on Targeted Protein Degradation Drug is a syndicated market report, published as Global Targeted Protein Degradation Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Targeted Protein Degradation Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
